<DOC>
	<DOCNO>NCT01527682</DOCNO>
	<brief_summary>Objectives : The study ass ocular hypotensive effect latanoprost dorzolamide select sample patient affect primary Pediatric Glaucoma ( PG ) , refractory surgical procedure . Safety assess , too.In first version protocol 96 eye forecast complete enrolment . The protocol amend complete study 68 eye include .</brief_summary>
	<brief_title>Efficacy Safety Topically Applied Medical Therapy Treatment Pediatric Glaucoma</brief_title>
	<detailed_description>Study design : Single arm , prospective , experimental study . Due ethical reason order adhere much possible current clinical practice , presence control arm plan . Due non-comparative nature study , blind treatment plan .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Carbonic Anhydrase Inhibitors</mesh_term>
	<criteria>Children either sex , age 012 year Diagnosis mono bilateral primary congenital glaucoma IOP great equal 22 mmHg low 27 mmHg Only one previous ocular hypotensive surgical procedure treatment glaucoma among follow : goniotomy , trabeculotomy , trabeculotomy adjunct mitomycin C ) ( medical treatment least one month ) Parent inform consent data processing ( registration ) Parent inform consent study procedure Secondary glaucoma ( SturgeWeber syndrome , type I neurofibromatosis , retinoblastoma , steroidinduced glaucoma , etc . ) Presence concomitant abnormality anterior segment eye ( cataract , iridocorneal dysgenesia , congenital uveal ectropion uvea , etc . ) Previous treatment study drug Presence concomitant systemic disease ( asthma , hypertension , cardiac disease , renal failure , etc . ) need treatment drug , could influence IOP ( steroid , betablockers , ACEinhibitors diuretic , etc . ) Abnormalities cornea could influence IOP reading ( mark cornea edema )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Intraocular pressure</keyword>
	<keyword>Latanoprost</keyword>
	<keyword>Dorzolamide</keyword>
</DOC>